Durham pharmas continue to see opportunities, challenges related to Covid-19


In earnings calls, Durham CEOs made the case to analysts that even after the pandemic, opportunities that emerged from Covid-19 will continue to boost the bottom line.

Previous Quintiles' Joan Gillings dies, leaves legacy of giving
Next In the pandemic, online homebuying picks up speed